Skip to main content
SpringerLink
Log in

Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background/aim

Atherosclerosis is evaluated by carotid mean intima-media thickness (mean IMT), pulse wave velocity (PWV), and the aortic calcification index (ACI). We have attempted to examine if these atherosclerotic parameters are associated with each other and which parameters are closely related to cardiac function in chronic HD patients.

Methods

The mean IMT, PWV and ACI were examined in 69 maintenance HD patients using carotid ultrasonography, a blood volume plethysmographic apparatus and abdominal CT, respectively. Echocardiographic studies were also performed for measuring left ventricular (LV) geometry. Serum total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglyceride, albumin, C-reactive protein (CRP), calcium and phosphate were measured.

Results

The mean IMT correlated positively with ACI (r = 0.461, P < 0.0001) and tended to be correlated with PWV, but did not reach statistical significance. The PWV value correlated positively with ACI (r = 0.494, P ≤ 0.0001). The mean IMT correlated positively with the LV mass index (r = 0.273, P = 0.0228), and fractional shortening (FS) correlated negatively with PWV value (r = −0.293, P = 0.0141) and ACI score (r = −0.289, P = 0.0158). Multivariate analyses indicated that the LV mass index was independently associated with mean IMT (P = 0.0231) as well as systolic blood pressure (P < 0.0001), pulse pressure (P < 0.0001) and hemoglobin (P = 0.016), and FS is independently associated with ACI (P = 0.0162) as well as PWV (P = 0.0144) and CRP (P = 0.0375).

Conclusion

Atherosclerosis and reduced LV function are associated with increased vascular calcification and arterial stiffness in chronic HD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.

    Article  PubMed  Google Scholar 

  2. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998–1999. J Am Soc Nephrol. 2005;16:489–95.

    Article  PubMed  Google Scholar 

  3. Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on Cardiovascular Disease. J Am Soc Nephrol. 1998;9(Suppl 12):S31–42.

    PubMed  CAS  Google Scholar 

  4. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in haemodialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995;47:884–90.

    Article  CAS  PubMed  Google Scholar 

  5. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27:347–54.

    Article  CAS  PubMed  Google Scholar 

  6. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transplant. 2000;15:1014–21.

    Article  CAS  PubMed  Google Scholar 

  7. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996;11:1277–85.

    Article  CAS  PubMed  Google Scholar 

  8. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.

    Article  CAS  PubMed  Google Scholar 

  9. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation. 1991;84:1280–7.

    Google Scholar 

  10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358–67.

    Article  CAS  PubMed  Google Scholar 

  11. Tanaka M, Babasono T, Takeda M, Iwamoto Y. Pulse pressure and chronic kidney disease in patients with type 2 diabetes. Hytertens Res. 2006;29:345–52.

    Article  Google Scholar 

  12. Nitta K, Akiba T, Suzuki K, Uchida K, Ogawa T, Majima K, et al. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res. 2004;27:47–52.

    Article  PubMed  Google Scholar 

  13. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002;25:359–64.

    Article  PubMed  Google Scholar 

  14. Nitta K, Akiba T, Uchida K, Kawashima A, Yumura W, Kabaya T, et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis. 2003;42:303–9.

    Article  CAS  PubMed  Google Scholar 

  15. Takei T, Otsubo S, Uchida K, Matsugami K, Mimuro T, Kabaya T, et al. Effects of sevelamer on the progression of vascular calcification in patients on chronic hemodialysis. Nephron Clin Pract. 2008;108:c278–83.

    Article  CAS  PubMed  Google Scholar 

  16. Gelev S, Spasovski G, Dzikova S, Trajkovski Z, Damjanovski G, Amitov V, et al. Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol. 2008;40:763–70.

    Article  CAS  PubMed  Google Scholar 

  17. Joint committee with the guidelines subcommittee of the Japan Academy of Neurosonology for ultrasonic assessment of carotid artery disease and the subcommittee for research into methods of screening atherosclerosis lesions. Guidelines for ultrasonic assessment of carotid artery disease: preliminary report. Neurosonology 2002; 15: 20–33.

    Article  Google Scholar 

  18. Shimada K. Japanese Society of Hypertension guidelines for the management of hypertension (JSH2004). Hypertens Res. 2006;29:7–14.

    Google Scholar 

  19. Davies MR, Hruska A. Pathophysiological mechanisms of vascular calcification in end stage renal disease. Kidney Int. 2001;60:472–9.

    Article  CAS  PubMed  Google Scholar 

  20. Stompor T, Rajzer M, Pasowicz M, Krasniak A, Sulowicz W, Kawecka-Jaszcz K, et al. Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int J Artif Organs. 2006;29:736–44.

    Article  CAS  PubMed  Google Scholar 

  21. Homma S, Hirose N, Ishida H, Ishii T, Araki G, Halsey JH. Carotid plaque and intima-media thickness assessed by B-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32:830–5.

    Article  CAS  PubMed  Google Scholar 

  22. Silverberg DS, Wexler D, Iaina A, Schwartz D. The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions. Clin Exp Nephrol. 2009;13:101–6.

    Article  CAS  PubMed  Google Scholar 

  23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–9.

    Article  CAS  PubMed  Google Scholar 

  24. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation. 2001;104:63–7.

    Article  CAS  PubMed  Google Scholar 

  25. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 1988;70:253–61.

    Article  CAS  PubMed  Google Scholar 

  26. Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 1990;21:1567–72.

    Article  CAS  PubMed  Google Scholar 

  27. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.

    Article  CAS  PubMed  Google Scholar 

  28. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953–60.

    Article  CAS  PubMed  Google Scholar 

  29. Ishimura E, Okuno S, Kitatani K, Maekawa K, Izumotani T, Yamakawa T, et al. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol. 2004;24:408–12.

    Article  PubMed  Google Scholar 

  30. Oikawa O, Higuchi T, Yamazaki T, Yamamoto C, Fukuda N, Matsumoto K. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol. 2007;11:304–8.

    Article  CAS  PubMed  Google Scholar 

  31. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–9.

    Article  CAS  PubMed  Google Scholar 

  32. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol. 1998;18:535–41.

    Article  CAS  PubMed  Google Scholar 

  33. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant. 2000;15:218–23.

    Article  CAS  PubMed  Google Scholar 

  34. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int. 2007;71:802–7.

    Article  CAS  PubMed  Google Scholar 

  35. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004;95:560–7.

    Article  CAS  PubMed  Google Scholar 

  36. Ketteler M, Westenfeld R, Schlieper G, Brandenburg V. Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol. 2005;9:265–70.

    Article  PubMed  Google Scholar 

  37. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245–52.

    Article  CAS  PubMed  Google Scholar 

  38. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815–24.

    Article  CAS  PubMed  Google Scholar 

  39. K/DOQI NKF: clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–S201.

    Google Scholar 

  40. Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, et al. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic hemodialysis patients. Nephrol Dial Transplant. 2005;20:760–7.

    Article  PubMed  Google Scholar 

  41. McMurray JJV, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting enzyme inhibitors: the CHARM-Added Trial. Lancet. 2003;362:767–71.

    Article  CAS  PubMed  Google Scholar 

  42. Nitta K, Akiba T, Suzuki K, Uchida K, Ogawa T, Majima K, Watanabe R, Aoki T, Nihei H. Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res. 2004;27:527–33.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the medical staff of the dialysis units in the Hidaka Hospital for collecting medical records. This work was supported by grants from the Japan Research Promotion Society for Cardiovascular Diseases and the International Research and the Educational Institute for Integrated Medical Sciences (IREIIMS).

Author information

Authors and Affiliations

  1. Department of Medicine, Kidney Center, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Mayuko Akamatsu, Tetsuya Ogawa, Ayuko Fujiu, Nami Matsuda & Kosaku Nitta

Authors
  1. Mayuko Akamatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuya Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayuko Fujiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nami Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kosaku Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsuya Ogawa.

About this article

Cite this article

Akamatsu, M., Ogawa, T., Fujiu, A. et al. Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients. Clin Exp Nephrol 13, 651–658 (2009). https://doi.org/10.1007/s10157-009-0220-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-009-0220-4

Keywords

Search

Navigation